Skip to main content
Clinical Trials/ITMCTR2000003500
ITMCTR2000003500CompletedPhase 1

The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial

Wuhan Hospital of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Inpatients in Wuhan Pulmonary Hospital (from January 30 to February 10, 2020) who meet the diagnostic criteria of COVID-19;
  • 2. Aged 18-75 years old;
  • 3. According to the fourth edition of guideline, meeting the mild and severe standards;
  • 4. Agreeing to participate in the trial;
  • 5. No antibiotics were used during one cycle of this treatment.

Exclusion Criteria

  • 1. According to the fourth edition of guideline, meeting the critical standard;
  • 2. Acute respiratory diseases not caused by 2019-nCoV;
  • 3. Asthma patients who need daily treatment;
  • 4. Severe lung interstitial lesions, bronchiectasis and other basic lung disease patients;
  • 5. Accompanied by severe primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformations, congenital heart disease, abnormal lung development and other basic diseases;
  • 6. pregnant women.

Investigators

Sponsor
Wuhan Hospital of Traditional Chinese Medicine

Similar Trials